Genitourinary Cancer

Among the tests offered for bladder and prostate cancer include UroVysion FISH, NMP-22, and PCA3 for prostate cancer prognosis. Circulating tumor cell counting (Cell Search) is available for assessing prostate cancer patient prognosis.
  • Medical Director, Cytopathology
    Dr. Chadwick is an associate professor of anatomic pathology at the University of Utah School of Medicine. She received her MD at Loma Linda University in California where she also served as a pathology fellow. Dr. Chadwick completed her residency in anatomic and clinical pathology at the University of Utah School of Medicine and was a cytopathology fellow at the University of Washington in Seattle. She is a member of the United States and Canadian Academy of Pathology, American Society of Cytopathology, and College of American Pathologists. Dr. Chadwick’s research interests include the use of molecular markers in cytopathology, pancreatic and biliary cancer, and cervical cancer screening.
  • Director, Surgical Pathology
    Dr. Liu is a professor of pathology at the University of Utah School of Medicine. Dr. Liu received her MD from Beijing University of Chinese Medicine and her MS in pathophysiology from Peking Union Medical College. She completed AP/CP residency training at Drexel University College of Medicine, a fellowship in hematology at Drexel University College of Medicine, and an oncologic/surgical fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Liu is an AP/CP and hematopathology-boarded pathologist. Her current research interests include oncologic clinical research.
  • Medical Director, Renal and Cardiovascular Pathology
    Dr. Revelo is a professor of pathology at the University of Utah School of Medicine. She received her MD from the Central University of Ecuador School of Medicine and her PhD in pathology from the Federal University of Minas Gerais in Brazil. Dr. Revelo completed her residency and a fellowship in renal pathology at Vanderbilt University Medical Center and is certified by the American Board of Pathology. Her research interests include mechanisms of chronic allograft and antibody mediated-rejection in kidney, heart, and pancreas transplants, mechanisms of glomerular diseases and molecular mechanisms of prostate carcinoma development and progression.
  • Section Head, Cytopathology
    Dr. Witt is an assistant professor of anatomic pathology at the University of Utah School of Medicine, where he serves as the residency rotation director for cytopathology. Dr. Witt received his MD at the University of Colorado Denver, School of Medicine and completed his AP/CP pathology residency at the University of Chicago (NorthShore) where he served as the chief resident during his last two years. He also completed a cytopathology fellowship at the University of Utah/ARUP Laboratories, and is board certified in anatomic and clinical pathology, with subspecialty boards in cytopathology. Dr. Witt is a member of the College of American Pathologists Cytopathology Committee, the American Society for Clinical Pathology, and the American Society of Cytopathologists. His research interests include studies related to fine-needle aspiration and head and neck pathology.